An estimate of rate of deviation from NCCN guideline recommendations for central nervous system imaging in trials forming basis for drug approval in first line advanced non-small cell lung cancer (NSCLC)

Peer Review reports

Original Submission
17 May 2021	Submitted	Original manuscript
15 Jul 2021	Reviewed	Reviewer Report - Aseem Bhatnagar
19 Jul 2021	Reviewed	Reviewer Report
20 Jul 2021	Reviewed	Reviewer Report
26 Oct 2021	Author responded	Author comments - Vinay Prasad
Resubmission - Version 2
26 Oct 2021	Submitted	Manuscript version 2
29 Oct 2021	Author responded	Author comments - Vinay Prasad
Resubmission - Version 3
29 Oct 2021	Submitted	Manuscript version 3
5 Nov 2021	Author responded	Author comments - Vinay Prasad
Resubmission - Version 4
5 Nov 2021	Submitted	Manuscript version 4
1 Dec 2021	Author responded	Author comments - Vinay Prasad
Resubmission - Version 5
1 Dec 2021	Submitted	Manuscript version 5
1 Dec 2021	Author responded	Author comments - Vinay Prasad
Resubmission - Version 6
1 Dec 2021	Submitted	Manuscript version 6
Publishing
4 Jan 2022	Editorially accepted
16 Jan 2022	Article published	10.1186/s12885-022-09179-y

Back to article page